CVX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Chevron Corp (CVX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has positive long-term fundamentals, recent financial performance and mixed sentiment from Congress trading, analysts, and options data suggest a cautious approach. The stock appears fairly valued with limited upside in the near term, and there are no strong trading signals or immediate catalysts to justify a buy right now.
The technical indicators show a mixed picture. The MACD is positive but contracting, RSI is neutral at 63.024, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are at S1: 173.55 and R1: 185.201, indicating limited room for significant upside in the short term.
Chevron's diversified operations have shown resilience, with downstream profits surging 75% despite falling upstream profits.
The company announced a 4% dividend increase, marking 38 consecutive years of dividend growth.
Analysts have raised price targets recently, with UBS setting a high target of $
Chevron's acquisition of Hess enhances its production capabilities in Guyana, solidifying its market position in South America.
Congress trading data indicates cautious sentiment, with more sell transactions (
than buys (4).
Financial performance in Q4 2025 showed declines in revenue (-5.27% YoY), net income (-14.48% YoY), and EPS (-23.63% YoY), reflecting weaker profitability.
HSBC downgraded the stock to Hold, citing stretched valuations after a 16% rally in
The stock's recent price performance has been weak, with a -1.84% regular market change and limited short-term upside potential based on candlestick patterns.
Chevron's Q4 2025 financials showed declining revenue (-5.27% YoY), net income (-14.48% YoY), and EPS (-23.63% YoY). However, gross margin improved to 31.79 (up 16.28% YoY), indicating operational efficiency. The company generated an additional $2.4 billion in cash flow from operations, supporting capital expenditures and dividend growth despite low oil prices.
Analyst sentiment is mixed but leans positive overall. Recent upgrades include UBS raising the price target to $212 and Argus increasing it to $203, both maintaining Buy ratings. However, HSBC downgraded the stock to Hold, citing valuation concerns. The average price target range is between $166 and $212, with a median target around $190, suggesting limited upside from the current price of $182.6.
